Challenges in the codevelopment of companion diagnostics
نویسندگان
چکیده
منابع مشابه
Challenges in the codevelopment of companion diagnostics
The goal of personalized medicine, to effectively customize diagnosis, treatment and prevention of disease to one’s genetic composition, is one that has been known and sought for many years. Increasingly, molecular companion diagnostics based on one’s inherited or somatic biomarkers are desired to ensure the effective, safe develop ment and application of a personalized drug. This has been ref...
متن کاملPersonalized Medicine in Oncology and Companion Diagnostics: Development and Challenges
The core of the whole concept of personalized medicine is to tailor medical practice, from prevention, diagnosis, treatment to prognosis, based on the underlying pathophysiological changes of the disease and the patient. More specifically, this approach may include new diagnostic tools to determine genetic alterations and expression, including the noncoding genetic elements, in order to more pr...
متن کاملAre companion diagnostics useful?
We define a companion diagnostics (CDx) test as any diagnostic tool that guides the selection of patient treatment. In the US, these tests include diagnostics cleared by the Food and Drug Administration (FDA), as well as laboratory-developed tests (LDTs) run in CLIA-accredited laboratories. The answer to the title’s question is obviously in the affirmative. We discuss the growing need to improv...
متن کاملthe effect of the record infancy in crimilly acts of guilties (in karaj city)
چکیده یکی از مهمترین دغدغه های بزرگ جوامع بشری، از دیر باز تا کنون که ذهن پژوهشگران و متخصصان بهداشت روانی و اجتماعی و دولتها رابه خود مشغول داشته، مسأله ی بزهکاری می باشد. شناخت کامل پدیده ی بزهکاری و بزهکار، علل وعوامل سقوط یک انسان، چگونگی درمان وی و درنهایت پیشگیری ازبزهکاری ودریک کلام سالم سازی یک جامعه، رسالت عظیم، انسانی ومقدسی می باشد که با بررسی شخصیت مجرم یعنی[ انسانی که تحت شرای...
15 صفحه اولCompanion diagnostics: changing patient management
At the European Multidisciplinary Cancer Congress (EMCC), held in Stockholm in September 2011, a recurring theme in many of the workshops was personalised medicine, including the latest developments in prognostic and predictive biomarkers. Such markers, it is hoped, will enable clinicians to use available resources to best effects-by offering treatments to only those patients most likely to ben...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Personalized Medicine
سال: 2012
ISSN: 1741-0541,1744-828X
DOI: 10.2217/pme.12.60